Arima S, Abe K, Kudo K, Tsunoda K, Yabe T, Imai Y, Saito T, Sato H, Yoshinaga K
Department of Clinical Biology and Hormonal Regulation, Tohoku University School of Medicine, Sendai, Japan.
Nihon Jinzo Gakkai Shi. 1991 Jun;33(6):597-604.
It is well known that hypertension (HT) frequently develops in patients with chronic glomerulonephritis (CGN) and that HT contributes to progression of CGN. So, proper antihypertensive therapy is required in hypertensive patients with CGN. However, there is so far no consensus of optimal blood pressure (BP) level to maintain the renal function in these patients. In order to evaluate the BP control level in the patients with renal insufficiency, we investigated the transition of BP and renal function in 22 CGN patients with HT (average age 36.5 +/- 9.9 years at the first medical examination, 15 male, 7 female, total 179.5 patient-years), who receive antihypertensive therapy for more than 5 years as outpatients at the second department of internal medicine of Tohoku University Hospital between 1975 and 1990. Renal biopsy had been performed in all these patients for CGN diagnosis. During this period 7 patients came to receive hemodialysis therapy from 5 to 10 (average 7.6 +/- 2.1) years after the first medical examination. In one of these 7 patients, the rate of decline in renal function accelerated after child-birth, and one after two years interruption of treatment. The other 13 patients are currently receiving drug treatments at our hospital. As a result, in CGN patients there was an optimal mean BP (MBP) control range, that is, when MBP was controlled in this range, the rate of decline in renal function became slow, but when MBP deviated from this range it became fast (p less than 0.01). Moreover, this range changed according to the serum creatinine (SCr) concentration level.(ABSTRACT TRUNCATED AT 250 WORDS)
众所周知,慢性肾小球肾炎(CGN)患者常并发高血压(HT),且高血压会促使CGN病情进展。因此,CGN合并高血压的患者需要进行适当的降压治疗。然而,目前对于维持这些患者肾功能的最佳血压(BP)水平尚无共识。为了评估肾功能不全患者的血压控制水平,我们调查了22例CGN合并HT患者(首次体检时平均年龄36.5±9.9岁,男性15例,女性7例,共179.5患者年)的血压和肾功能变化情况。这些患者于1975年至1990年在东北大学医院内科第二科室门诊接受了5年以上的降压治疗。所有患者均进行了肾活检以诊断CGN。在此期间,7例患者在首次体检后5至10年(平均7.6±2.1年)开始接受血液透析治疗。在这7例患者中,有1例产后肾功能下降速度加快,1例在治疗中断两年后出现这种情况。另外13例患者目前在我院接受药物治疗。结果显示,CGN患者存在一个最佳平均血压(MBP)控制范围,即当MBP控制在该范围内时,肾功能下降速度变慢,但当MBP偏离该范围时则变快(p<0.01)。此外,该范围会根据血清肌酐(SCr)浓度水平而变化。(摘要截取自250字)